Although L-asparaginase is an effective drug for adolescent acute lymphoblastic leukemia [31], the therapeutic efficacy of L-asparaginase in other solid tumors is not satisfactory due to intolerable toxicity in patients and L-asparaginase resistance of the tumor [56]. Here, ASPG is linked to neoplasm.